
BeatO
Offering Comprehensive, Clinically Proven Care Programs to Prevent, Control, and Reverse Diabetes.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $33.0m | Series B | |
Total Funding | 000k |
USD | 2019 | 2020 | 2021 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 40 % | 55 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
BeatO, operating under Health Arx Technologies Pvt. Ltd., is a Delhi-based digital health company established in 2015 by Gautam Chopra, Yash Sehgal, and Abhishek Kumar. The company's genesis is rooted in the personal experiences of co-founders Gautam Chopra and Yash Sehgal, school friends who were both diagnosed with diabetes in their early 30s. This firsthand struggle with managing the chronic condition revealed a fragmented healthcare system and the absence of a comprehensive solution, which motivated them to leave their corporate careers and create BeatO.
Gautam Chopra, the CEO, holds an MBA from the Indian School of Business (ISB), Hyderabad, and had a background in international business strategy, including a role at Lufthansa in Brussels. Yash Sehgal, the COO, has an MBA from the Indian Institute of Management, Kozhikode, and possesses extensive experience in operations and supply chain. The founding team was completed by Abhishek Kumar, an ISB batchmate of Chopra's, who brought over a decade of software development experience to the role of CTO. Another co-founder, Kunal Kinalekar, also serves as the company's CTO.
BeatO operates as a full-stack digital platform focused on diabetes and other chronic condition management, primarily serving the Indian market with recent expansion into Singapore. The business model is direct-to-consumer (B2C), targeting individuals with diabetes. The core of its offering is a smartphone-enabled glucometer that syncs with the BeatO mobile application. This integration allows for real-time blood glucose tracking, data analysis, and personalized insights. When a user's readings are outside the normal range, the system can trigger alerts, connecting them with doctors and diabetes educators for immediate guidance.
Revenue is generated through a subscription-based model for its comprehensive care programs and the sale of diabetes-specific products. The platform serves as a marketplace offering a wide array of products and services, including diabetes-friendly foods, snacks, footwear, diagnostic services, medication refills, and insurance products. The company's diabetes care programs are clinically proven and provide users with access to a team of diabetologists, health coaches, and nutritionists who create customized treatment and diet plans. The platform also integrates with fitness trackers to provide a holistic view of a user's health.
Since its inception, BeatO has secured significant funding, raising a total of $50.8 million over 12 rounds from investors such as Lightrock India, HealthQuad, Flipkart Ventures, Orios Venture Partners, and Blume Ventures. The company has demonstrated substantial growth, serving over 3 million users and expanding its reach, particularly into Tier 3 and 4 cities in India. Its contributions to making diabetes care affordable and accessible have been recognized with the National Startup Award in Healthcare.
Keywords: diabetes management, digital health platform, chronic condition management, smartphone glucometer, tele-consultation, health monitoring, diabetes care programs, blood glucose tracking, healthtech, personalized healthcare, medical devices, remote patient monitoring, diabetes products marketplace, mobile health, AI in healthcare, venture capital, Series B, India, Singapore, cardiometabolic health
Tech stack
Investments by BeatO
Edit